drugset / Trial / NCT02587416

Effect of Gemcabene on the Pharmacokinetics of Atorvastatin in Healthy Volunteers

NCT02587416

Phase 1 Completed 20 enrolled NeuroBo Pharmaceuticals Inc.
Non-randomizedCrossoverOpen-labelBasic science

Summary

The purpose of this study is to determine the effect of gemcabene on the pharmacokinetics of atorvastatin 80 mg

Timeline

Start
2002-11
Primary completion
2002-12
Completion
2002-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 80 mg Oral
Subject Gemcabene Small molecule 300 mg Oral
Subject Gemcabene Small molecule 900 mg Oral

Indications